Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell

See also
Status	Clinical Trial	Phase
Completed	`NCT00341939` - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed	`NCT00038025` - A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies	Phase 2
Not yet recruiting	`NCT02881749` - Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides	Phase 2
Completed	`NCT00744991` - A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma	Phase 2
Completed	`NCT00099593` - Immunization Against Tumor Cells in Sezary Syndrome	Phase 2
Completed	`NCT02593045` - Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)	Phase 1
Recruiting	`NCT00779896` - Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study	Phase 1/Phase 2
Recruiting	`NCT00177268` - Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Completed	`NCT01728805` - Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL	Phase 3
Withdrawn	`NCT00969085` - Trial of Curcumin in Cutaneous T-cell Lymphoma Patients	Phase 2
Completed	`NCT00412997` - LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma	Phase 1
Completed	`NCT00254332` - Effect of Denileukin Diftitox on Immune System in CTCL Patients	N/A
Recruiting	`NCT04296786` - Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study	Phase 2
Recruiting	`NCT06285370` - A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy	Phase 4
Completed	`NCT00071084` - Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.	Phase 2
Completed	`NCT00896493` - Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma	Phase 2
Terminated	`NCT00699296` - Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma	Phase 2
Completed	`NCT02676778` - Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma	Phase 2
Terminated	`NCT02061449` - Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma	Phase 1
Completed	`NCT01134341` - Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma	Phase 1

NCT number	NCT00425555
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	January 2007
Completion date	June 2013

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms